Pamicell, Top Search Ranking... Stock Price -1.59%

As of 1:30 PM on the 12th, Pamicell is trading at 18,600 KRW, down 1.59% from the previous day. This represents a 12.06% decrease compared to September 8. Pamicell is known as a bio-pharmaceutical company that developed the world's first stem cell therapy.

Today, foreigners are tentatively recorded as net sellers of 10,000 shares. Over the past five days, individual investors have been net buyers of 146,160 shares, while foreigners and institutions have been net sellers of 117,490 shares and net buyers of 10,360 shares, respectively.

On October 5, Pamicell became a market issue with the headline 'Soars on news of President Trump's Remdesivir treatment.'

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.